THE MISSION AND PURPOSE OF THE NEW RESTRICTED .SANOFI gTLD IS TO BENEFIT INTERNET USERS BY ENSURING INCREASED TRUST, CONVENIENCE AND UTILITY. The .sanofi gTLD will create a new generation gTLD serving the interests of end users by providing an authoritative Internet space where information,... Read more
THE MISSION AND PURPOSE OF THE NEW RESTRICTED .SANOFI gTLD IS TO BENEFIT INTERNET USERS BY ENSURING INCREASED TRUST, CONVENIENCE AND UTILITY.
The .sanofi gTLD will create a new generation gTLD serving the interests of end users by providing an authoritative Internet space where information, services and resources of Sanofi, and its affiliates, will be closely controlled by Sanofi. The majority of the anticipated domain name registrations in the .sanofi gTLD will be used in the promotion and communication of the Sanofi brand and other related services. A subset of domain names has the potential to be created and used for communication and marketing purposes, with internet users assured of brand authenticity.
As the new .sanofi gTLD expands and evolves, Sanofi may consider allowing its distribution network and other parties associated with the distribution of Sanofi products and solutions, or otherwise associated with the Sanofi brand and range of products and services, to register second-level domains at a later date.
Sanofi is a global and diversified healthcare leader, which discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in healthcare, with 6 growth platforms: emerging markets, vaccines, consumer healthcare, diabetes treatments, innovative products and animal health. Through the acquisition of Genzyme, Sanofi has strongly reinforced its footprint in rare diseases. Sanofi works to protect the health of the earth's 7 billion inhabitants, improve their quality of life and respond to their potential needs. Sanofi is continually creating new approaches to its activities and work sectors, and are mobilized for the primary goal of bringing medicines and vaccines to patients. To make tomorrow's therapeutic solutions real, Sanofi seeks to innovate with its partners, who, like Sanofi, aim for excellence and efficiency.
In this regard, consumer trust, reach and continuous innovation are paramount considerations in all its activities.
Since the inception of the current domain name system, business activities conducted on the internet are constantly changing and evolving with increased complexity. The volume of commercial transactions over the internet is constantly growing and bringing benefits of simplicity and lowered transaction costs to businesses and consumers. However, at the same time, criminal activities over the internet including data breaches, identity theft, hacking and phishing activities, have also become more sophisticated resulting in loss of consumer confidence as well as causing both financial and non-financial harm, and reputational damage to consumers and organisations. The .sanofi gTLD will facilitate greater trust and assurance from internet users connecting with Sanofi online, whilst still allowing convenient and efficient interaction.
Sanofi's mission and purpose of the proposed new gTLD share ICANN's initiatives to promote public interest. Sanofi is committed to contribute towards achieving such initiatives in line with ICANN's Affirmation of Commitments, which includes:
- consumer trust: the .sanofi gTLD registry will be operated in a centralised manner with a restrictive registration policy. Registration of domain names will only be available to Sanofi and its affiliate entities at this stage, which will provide added consumer trust that .sanofi domain names are trustworthy. With .sanofi domain names being subject to strict registration standards, policies and procedures under Sanofi's control, the potential for malicious conduct within the .sanofi domain space will be removed;
- competition: the proposed new gTLD is not intended to instigate competition and consumer choice among prospective registrants of domain names at the second or even, third, level. Instead it is anticipated to contribute to ICANN's initiatives to promote public interest through its operation focused on promoting consumer trust. Increased trust in the .sanofi gTLD will drive existing and new top level domain (TLD) registry operators to make improvements in mechanisms to improve consumer trust of their TLDs; and
- consumer choice: the proposed new gTLD will enable user-driven improvements and innovations assisting Sanofi's marketing efforts through its ability to create new second and third level domain names on demand. These names will provide the consumers with more choices for interacting with Sanofi. As Sanofi has effective control over the registration and use of domain names under .sanofi domain space, this will also contribute towards general service innovations on the internet.
Given the restricted nature of the .sanofi gTLD, the projected number of registration is likely to be limited. It is anticipated that about 50 to 400 domain names will be registered in the first few years. However, the number of registrations is likely to increase as Sanofi develops and implements new services and marketing campaigns and potentially expands the eligibility criteria for registrants to include its distribution network.
As the new .sanofi gTLD expands and evolves to extend use of second level domain names to distribution network and other parties who may be associated with Sanofi products and services, Sanofi will continue to comply with all operational, technical and policy requirements of operating a registry, as well as maintaining consumer trust and the stability of the internet. Sanofi will keep ICANN reasonably informed of any material developments relating to the .sanofi gTLD including compliance with the continued operations instrument obligations as set out in Specification 8 of the Registry Agreement.
Sanofi is a well-recognised global brand with its trademarks registered in more than 78 countries and territories for the following classes such as: Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary use, food for babies; dietary supplements for humans and animals; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides (class 05); Scientific, optical, signalling, checking (supervision), life-saving and teaching apparatus and instruments; (class 09); Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials (class 10); Telecommunications (class 38); Treatment of materials (class 40); Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software (class 42); and Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services (class 44). Sanofi owns 140 denominations matching or including the term "SANOFI" ie 2000 applications / registrations on a country basis, among a portfolio of 90 000 applications / registrations through the world.
Further, Sanofi has existing domain names with an exact match to "sanofi" in 124 country-code TLDs (ccTLDs) and 11 gTLDs; and existing domain names which include "sanofi" in 203 gTLDs and 561 ccTLDs.
Recently, Sanofi was successful in securing domain name registrations during the sunrise phases for the following domain spaces based on existing trademark registration: .xxx, .qa, .eu, .mx and .asia. The domain names succesfully registered in this manner were sanofi.xxx, sanofi.qa, sanofi.eu, sanofi.mx and sanofi.asia.
Sanofi believes that the .sanofi gTLD is unlikely to cause confusion with either a generic term or any existing TLDs. Sanofi trademarks are a leading global brand with significant reputation globally.×